Radnostix, Inc. (INIS)

Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio